Skip to main content

Management Implications of Hypertrophic Cardiomyopathy Patients with Massive Hypertrophy

  • Chapter
  • First Online:
Cardiac Electrophysiology
  • 100 Accesses

Abstract

Management considerations are discussed for HCM patients with massive LV hypertrophy including consideration for primary prevention implantable cardioverter defibrillator placement, and increased risk of progressive heart failure symptoms secondary to obstruction, relieved with myectomy. With treatment these individuals with the most extreme HCM phenotype can achieve extended longevity with low mortality risks.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med. 2018;379(20):1977.

    PubMed  Google Scholar 

  2. Rowin EJ, Maron BJ, Romashko M, Wang W, Rastegar H, Link MS, et al. Impact of effective management strategies on patients with the most extreme phenotypic expression of hypertrophic cardiomyopathy. Am J Cardiol. 2019;124(1):113–21.

    Article  Google Scholar 

  3. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778–85.

    Article  CAS  Google Scholar 

  4. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. Circulation. 2011;124:e783–831.

    PubMed  Google Scholar 

  5. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ethan J. Rowin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Romashko, M., Rowin, E.J. (2020). Management Implications of Hypertrophic Cardiomyopathy Patients with Massive Hypertrophy. In: Natale, A., Wang, P., Al-Ahmad, A., Estes, N. (eds) Cardiac Electrophysiology. Springer, Cham. https://doi.org/10.1007/978-3-030-28533-3_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28533-3_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28531-9

  • Online ISBN: 978-3-030-28533-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics